Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive-Reference-Cited by-同舟云学术

Patterns of treatment and BRAF testing with immune checkpoint inhibitors and targeted therapy in patients with metastatic melanoma presumed to be BRAF positive

Published:2019-06 Issue:3 Volume:29 Page:301-310
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Ghate Sameer,Ionescu-Ittu Raluca,Burne Rebecca,Ndife Briana,Laliberté François,Nakasato Antonio,Duh Mei Sheng

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference42 articles.

1. Cancer statistics, 2017;Siegel;CA Cancer J Clin,2017

2. Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma;Chapman;J Clin Oncol,1999

3. Mutations of the BRAF gene in human cancer;Davies;Nature,2002

4. The clinical significance of BRAF and NRAS mutations in a clinic-based metastatic melanoma cohort;Ekedahl;Br J Dermatol,2013

5. Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma;Long;J Clin Oncol,2011

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world treatment patterns and outcomes for patients with advanced melanoma treated with immunotherapy or targeted therapy;Pharmacoepidemiology and Drug Safety;2023-04-24

2. A Mathematical Model for the Treatment of Melanoma with the BRAF/MEK Inhibitor and Anti-PD-1;Applied Sciences;2022-12-06

3. Real-world outcomes of different lines and sequences of treatment in BRAF-positive advanced melanoma patients;Melanoma Research;2022-10-15

4. Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer Center;JCO Oncology Practice;2022-05

5. Treatment patterns of melanoma by BRAF mutation status in the USA from 2011 to 2017: a retrospective cohort study;Melanoma Management;2019-12-01